Disparity between serological reactivity to Borrelia burgdorferi and evidence of past disease in a high-risk group

Clinical Infectious Diseases

Volumn 27, Issue 5, 1998, Pages 1210-1213

  Arteaga, Fernando ^b   Golightly, Marc G ^b   Perez, Ana Garcia ^b   Barral, Marta ^b   Anda, Pedro ^b   Garcia Monco, Juan C ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CROSS REACTING ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; OCCUPATION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SPAIN;

EID: 0032466550     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514970     Document Type: Article

References (19)

1. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis J. Lyme disease - a tick borne spirochetosis? Science 1982; 216:1317-9.
2. Steere AC. Lyme disease. N Engl J Med 1993; 321:586-96.
3. García-Moncó JC, Benach JL. Lyme neuroborreliosis. Ann Neurol 1995; 37:691-702.
4. Münchhoff P, Wilske B, Preac-Mursic V, Schierz G. Antibodies against Borrelia burgdorferi in Bavarian forest workers. Zentralbl Bakteriol Hyg 1986; 263:412-9.
5. Stanek G, Flamm H, Sticht-Groh V, et al. Epidemiology of borrelia infections in Austria. Zentralbl Bakteriol Hyg 1986; 263:442-9.
6. Guy EC, Bateman DE, Martyn CN, Heckels JE. Lyme disease: prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workers. Lancet 1989; 1:484-6.
7. Fahrer H, van der Linden SM, Sauvain MJ, et al. The prevalence and incidence of clinical and asymptomatic Lyme borreliosis in a population at risk. J Infect Dis 1991; 163:305-10.
8. Oteo JA, Casas JM, Martinez de Artola V. Lyme disease in outdoor workers: risk factors, preventive measures and tick removal methods. Am J Epidemiol 1991; 133:754-5.
9. Kuiper H, van Dam AP, Moll AW, et al. One year follow up study to assess the prevalence and incidence of Lyme borreliosis among Dutch forestry workers. Eur J Clin Microbiol Infect Dis 1993; 12:413-8.
10. Anda P, Rodriguez I, De la Loma A, et al. A serological survey and review of clinical Lyme borreliosis in Spain. Clin Infect Dis 1993; 16:310-9.
11. Johnson BJB, Robbins KE, Bailey RE, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 1993; 167:392-400.
12. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400.
13. Anonymous. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep 1990; 39:19-21.
14. García-Moncó JC, Coleman JL, Galbe JL, et al. Caracterización de una cepa española de Borrelia burgdorferi. Med Clin (Barc) 1991; 98: 89-93.
15. Oteo JA, Anda A, Backenson PB, et al. Use of the C3H/He Lyme disease mouse model for the recovery of Borrelia garinii from erythema migrans lesions. Res Microbiol 1998; 149:39-46.
16. Sadziene A, Thompson PA, Barbour AG. In vitro inhibition of Borrelia burgdorferi growth by antibodies. J Infect Dis 1993; 167:165-72.
17. Le Fleche A, Postic D, Girardet K, Peter K, Peter O, Baranton G. Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997; 47:921-5.
18. Wang G, van Dam AP, Le Fleche A, et al. Genetic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol 1997; 47:926-32.
19. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. JAMA 1993; 269:1812-6.